Navigation Links
Non-Drug ADHD Treatments Don't Pan Out in Study

By Barbara Bronson Gray
HealthDay Reporter

WEDNESDAY, Jan. 30 (HealthDay News) -- Many parents pursue costly and time-consuming treatments to help their children with attention-deficit/hyperactivity disorder. Now, a new study finds little evidence that non-drug interventions reduce key symptoms of ADHD.

A multinational team of experts identified no positive effects from psychological treatments including mind exercises (cognitive training), neurofeedback and behavioral training (positive reinforcement). And the researchers discovered only small benefits associated with dietary treatments: supplementation with omega-3 and omega-6 free fatty acids, and elimination of artificial food coloring.

Still, parents shouldn't be discouraged, said study co-author Dr. Emily Simonoff.

"I think our findings allow a much more informed discussion than did previous work because we've been able to demonstrate that what we once thought worked is more limited and more questionable," said Simonoff, a professor of child and adolescent psychiatry at King's College London.

Simonoff thinks the study conclusions need to be interpreted in the context of a child's particular situation.

"I think people need to talk with their child's clinician," she said. "Evidence is never a substitute for having a discussion about your own child and what is right for your child and your family."

ADHD diagnoses are on the rise. Between 1997 and 2007, diagnoses among U.S. children and teens increased between 3 percent and 6 percent a year, according to the U.S. Centers for Disease Control and Prevention. According to the American Psychiatric Association, between 3 percent and 7 percent of U.S. children have the condition, which makes it hard to focus in school and to sustain friendships. Currently, a combination of medication and behavior therapy is the recommended treatment, according to the CDC.

The new review, an analysis of 54 studies by the European ADHD Guidelines Group, compared "blinded" and "unblinded" ratings for several dietary and psychological treatments. "Blinded" raters are unaware of the treatment used, while "unblinded" judges know of the therapy. It is thought that blinded ratings eliminate bias.

The study, published online Jan. 30 in the American Journal of Psychiatry, found that treatments were rated more effective in the unblinded tests, which appears to invalidate the conclusions.

Even after learning of the study findings, some people might say it can't hurt to try a particular therapy. But Simonoff warned of potential negative side effects.

"Adverse effects are often associated with pharmacological therapies, but other interventions can have them as well," she said. "For example, does a highly selective diet limit the way a child can play and socialize, making them feel different from their friends? And for parents, if a child doesn't improve under these therapies, does it affect how the parents feel about themselves?"

Dr. Andrew Adesman, chief of developmental and behavioral pediatrics at Steven and Alexandra Cohen Children's Medical Center of New York in New Hyde Park, agreed: "The danger in saying it won't hurt [to use non-drug therapies] is, where do you draw the line and what's the rationale?"

Attempting other therapies "instead of something that works," he said, results in lost time and money, false hopes, and missed opportunities.

Adesman said, however, that he was surprised that behavioral therapy was not found to be effective. "Unlike neurofeedback, elimination diets or attention training, the American Academy of Pediatrics does recommend behavioral therapy for ADHD in children," he said. "It involves psychologists working with parents to elicit better behavior in their kids, using positive and negative reinforcement, like time-outs."

Even if therapy doesn't improve the core symptoms of ADHD, such as attention span and impulsiveness, it may provide other benefits to the child and family, such as teaching effective communication strategies, Adesman said.

He also encourages parents to be open to the potential benefit drug therapy may provide.

"When I hear parents say they'll consider medicine only as a last resort, that's dangerous," he said. "Parents should confer with their child's pediatrician and discuss a range of treatment approaches and recognize that often the reason a medicine is suggested is not because of a physician's bias but rather because the data is generally stronger than for other treatments."

The European ADHD Guidelines Group received support for the study from Brain Products GMBH and drug makers Janssen-Cilag, Lilly, Medice, Shire and Vifor Pharma.

More information

Learn more about ADHD from the U.S. Centers for Disease Control and Prevention.

SOURCES: Emily Simonoff, M.D., professor of child and adolescent psychiatry, head of department, Institute of Psychiatry, King's College London; Andrew Adesman, M.D., chief of developmental and behavioral pediatrics, Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park; Jan. 30, 2013, American Journal of Psychiatry

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
2. Research May Point to New Obesity Treatments
3. Researchers make promising discovery in pursuit of effective lymphoma treatments
4. Study examines treatments for relieving breathing difficulties among patients with lung effusions
5. LA BioMeds Dr. Patricia Dickson researching treatments for neurodegenerative disorders
6. Pre-op Treatments Boost Survival for Esophageal Cancer Patients: Study
7. 1960s-era anti-cancer drug points to treatments for Lou Gehrigs disease
8. Rejuv Medical In Sartell, MN Now Offering Stem Cell Treatments
9. MDS researchers join forces to advance patient treatments and outcomes
10. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines
11. Few Migraine Sufferers Referred for Behavioral Treatments
Post Your Comments:
Related Image:
Non-Drug ADHD Treatments Don't Pan Out in Study
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
(Date:6/23/2016)... 23, 2016 Bracket , a leading clinical ... generation clinical outcomes platform, Bracket eCOA (SM) 6.0, at ... 26 – 30, 2016 in Philadelphia , ... Outcome Assessment product of its kind to fully integrate with ... Bracket eCOA 6.0 is a flexible platform for electronic clinical ...
Breaking Medicine Technology: